NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that its first quarter revenues increased a fraction of 1 percent year over year. 

For the three months ended March 28, the company recorded revenues of $3.92 billion, up from $3.90 billion in the year-ago quarter, and short of the average analysts' estimate of $4.00 billion. Organic revenue growth was 2 percent year over year in the quarter, Thermo Fisher CFO Peter Wilver said on a conference call following the release of the company's financial results. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.